Tavaborole D2
| Product Name | Tavaborole D2 |
|---|---|
| Alternate Names | Tavaborole Stable Isotopes, Stable Isotopes of Tavaborole |
| CAT No. | CS-O-32649 |
| CAS No. | 174671-46-6 (Unlabeled) |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 153.94 g/mol |
| Mol. For. | C₇H₄D₂BFO₂ |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Tavaborole |
| Purity | 95% |
| Therapeutic | Anti-Fungals |
| Smileys | FC1=CC(C([2H])([2H])OB2O)=C2C=C1 |
| Canonical Smiles | B1(C2=C(CO1)C=C(C=C2)F)O |
| InchIKey | LFQDNHWZDQTITF-UHFFFAOYSA-N |
| Inchl | InChI=1S/C7H6BFO2/c9-6-1-2-7-5(3-6)4-11-8(7)10/h1-3,10H,4H2 |
| IUPAC | 5-fluoro-1-hydroxy-3H-2,1-benzoxaborole |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Tavaborole D2 is a topical antifungal medication used to treat toenail fungus. It is available in the form of a solution which is applied to the affected toenail once daily. The medication works by blocking the production of an enzyme that is essential for the growth of the fungus.
Tavaborole D2 belongs to a class of drugs called oxaboroles. It is a boron-containing organic compound with a molecular weight of 257.98 g/mol. The chemical formula for Tavaborole D2 is C7H6BNO2. The medication has a white to off-white crystalline appearance and is highly soluble in water.
Tavaborole D2 has been clinically proven to be effective in the treatment of toenail fungus. In a randomized double-blind study, it was found that 31.1% of patients treated with Tavaborole D2 had complete cure of their toenail fungus after 48 weeks of treatment, compared to 7.2% of patients treated with a placebo solution.
Tavaborole D2 is generally well-tolerated with no serious adverse effects reported. The most common side effects include redness, itching, and irritation at the application site. It is important to follow the instructions provided by your healthcare provider when using Tavaborole D2 to ensure maximum effectiveness and safety.
Get an Instant Quote
Related Compounds
Tavaborole D3 | Tavaborole 13Cd2 |